Plasma Interleukin-6 Level: A Potential Prognostic Indicator of Emergent HBV-Associated ACLF.
Zhe-Bin WuYu-Bao ZhengKe WangZhi-Shuo MoXu ZhenYing YanZhi-Liang GaoPublished in: Canadian journal of gastroenterology & hepatology (2021)
A high plasma IL-6 level in CHB patients could be an early biomarker for HBV-ACLF.